Nancy Rigotti, MD
Professor of Medicine, Harvard Medical School Founding Director, Tobacco Research and Treatment Center, Massachusetts General Hospital Nancy Rigotti, MD, a Professor of Medicine at Harvard Medical School and Associate Chief of the Division of General Internal Medicine at Massachusetts General Hospital, is internationally known for her leadership to promote smoking cessation, especially the delivery of tobacco treatment in health care systems. Dr. Rigotti is Past President of both the Society for Research in Nicotine and Tobacco and the Society of General Internal Medicine and she founded and directs Mass General Hospital’s Tobacco Research and Treatment Center, a multi-disciplinary team that aims to improve the delivery of tobacco treatment interventions across health care settings in the US and internationally. This work includes developing, evaluating, and implementing new tobacco cessation treatments. For the past decade, she has studied cytisine, a naturally-occurring plant-based alkaloid, for its effectiveness to aid smoking cessation and its potential to become an affordable treatment available to tobacco users worldwide. Dr. Rigotti also studies electronic cigarettes as smoking cessation and harm reduction tools.. She was a member of the National Academies of Science, Engineering, and Medicine panel that produced the 2018 report, Public Health Consequences of E-Cigarettes, a scientific co-editor of the 25th anniversary U.S. Surgeon General’s Report, and is a member of the FDA Center for Tobacco Products’ Tobacco Products Scientific Advisory Committee.